← Back to CGON

CG Oncology, Inc. - Common stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 06/08/2026Sep 2025Filed 14/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 06/08/2026Sep 2024Filed 14/11/2025Jun 2024Filed 14/11/2025Mar 2024Filed 14/11/2025
$1.2$1.1$1.7$0$0.1$0$0.1$0.5
−$79−$60−$44−$41−$34−$20−$19−$17
−$0.90−$0.71−$0.57−$0.54−$0.45−$0.30−$0.28−$0.36
8885777676676747

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.